Compare Dow Inc (DOW) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Inc vs 22nd Century Group Inc — how do they compare? Dow Inc trades at $28.42 (market cap $20.65B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Dow Inc is far larger — about 33217× 22nd Century Group Inc's market cap, and Dow Inc pays a 4.9% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dow Inc for 82 Days and 22nd Century Group Inc for 32 Days on average.
| DOW | XXII | |
|---|---|---|
Market Cap | $20.65B | $621.67K |
Volume | 14,126,943 | 45,625 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $41.87 | $483.00 |
52-Week Low | $20.65 | $0.80 |
Typical Hold Time | 82 Days | 32 Days |
Enterprise Value | $36.34B | -$3.69M |
Dividend Yield | 4.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOW trades at $28.59, up 2.95% today, near the analyst low target of $28.00. The stock shows a bullish technical signal despite mixed indicators, with recent earnings beats in Q4 2025 through Q2 2026. However, fundamentals are weak, with a negative net income margin of -3.13% in 2025 and declining revenue from $56.9B in 2022 to $40.0B in 2025. Cash flow trends improved in 2025, but debt-to-asset ratios have risen to 29.87%.
The outlook is cautious; while analyst consensus is a buy with a $34.22 target, high valuation (P/E 75.93) and profitability challenges pose risks. Opportunities include dividend stability and potential margin recovery, but investors face headwinds from cyclical demand and competitive pressures in the chemicals sector.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
